These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30723583)

  • 1. Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer.
    Kurzrock R; Hickish T; Wyrwicz L; Saunders M; Wu Q; Stecher M; Mohanty P; Dinarello CA; Simard J
    Oncoimmunology; 2019; 8(3):1551651. PubMed ID: 30723583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis.
    Solomonidi N; Vlachoyiannopoulos PG; Pappa M; Liantinioti G; Ktena S; Theotikos E; Elezoglou A; Netea MG; Giamarellos-Bourboulis EJ
    iScience; 2023 Sep; 26(9):107670. PubMed ID: 37680472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
    Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
    Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.
    Fisher CJ; Slotman GJ; Opal SM; Pribble JP; Bone RC; Emmanuel G; Ng D; Bloedow DC; Catalano MA;
    Crit Care Med; 1994 Jan; 22(1):12-21. PubMed ID: 8124953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis.
    Bresnihan B
    Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):17-20. PubMed ID: 11357167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-1ra levels in monocyte cultures and synovial fluids.
    Towbin H; Schmitz A; van Oostrum J; Seitz M; Dewald B; Zingel O; Motz J; Vosbeck K; Rordorf C
    J Immunol Methods; 1994 Mar; 170(1):125-35. PubMed ID: 8157985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
    Ito H; Miki C
    Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases.
    Terui T; Hirao T; Sato Y; Uesugi T; Honda M; Iguchi M; Matsumura N; Kudoh K; Aiba S; Tagami H
    Exp Dermatol; 1998 Dec; 7(6):327-34. PubMed ID: 9858135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of endotoxin on LH secretion in the ovariectomized monkey are prevented by naloxone but not by an interleukin-1 receptor antagonist.
    Xiao E; Xia-Zhang L; Ferin M
    Neuroimmunomodulation; 2000; 7(1):6-15. PubMed ID: 10601814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.
    Mandrup-Poulsen T; Wogensen LD; Jensen M; Svensson P; Nilsson P; Emdal T; Mølvig J; Dinarello CA; Nerup J
    Crit Care Med; 1995 Jan; 23(1):26-33. PubMed ID: 8001382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
    Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
    Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
    Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
    Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist expression in epithelial cells of human endometrium.
    Fukuda M; Azuma C; Kanai T; Koyama M; Kimura T; Saji F
    Int J Gynaecol Obstet; 1995 Jun; 49(3):305-10. PubMed ID: 9764870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy.
    Schwaighofer H; Oberhuber G; Hebart H; Einsele H; Herold M; Nachbaur D; Eibl B; Tilg H; Kropshofer G; Ferrara JL; Niederwieser D
    Transplantation; 1997 Jan; 63(1):52-6. PubMed ID: 9000660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy.
    Hofbauer LC; Mühlberg T; König A; Heufelder G; Schworm HD; Heufelder AE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2244-7. PubMed ID: 9215301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat.
    Cartmell T; Luheshi GN; Hopkins SJ; Rothwell NJ; Poole S
    J Physiol; 2001 Feb; 531(Pt 1):171-80. PubMed ID: 11179401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on IL-1alpha, IL-1beta and sIL-1ra in sera of patients with Graves' ophthalmopathy.
    Liu G; Wu Z; Yang H; Lin Z; Chen T; Liang Y; Huang X; Wu H
    Yan Ke Xue Bao; 2002 Sep; 18(3):151-5. PubMed ID: 15510744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254).
    Kraus VB; Birmingham J; Stabler TV; Feng S; Taylor DC; Moorman CT; Garrett WE; Toth AP
    Osteoarthritis Cartilage; 2012 Apr; 20(4):271-8. PubMed ID: 22273632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.